Commentary

Video

What Pharmacists Should Understand When Assessing, Treating Patients With Ovarian Cancer With Rucaparib

Thomasina Morris, RPh, MHA, BCOP, pharmacist at Moffitt Cancer Center, discusses what oncology pharmacists should understand about rucaparib when treating ovarian cancer.

Pharmacy Times interviewed Thomasina Morris, RPh, MHA, BCOP, pharmacist at Moffitt Cancer Center, on what rucaparib is used to treat and how its mechanism of action works to fight cancer.

During the interview, Morris addressed what oncology pharmacists should understand when assessing and treating patients with ovarian cancer with rucaparib.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Inflammation concept, inflammated human tissues 3d rendering - Image credit: picture-waterfall | stock.adobe.com
Austin Texas | Image credit: Kevin Ruck - stock.adobe.com
Pharmacy Times OPC